REGEN BIOPHARMA, INC. (RGBP) Net income 2017–2026
REGEN BIOPHARMA, INC. (RGBP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$1.3MFY2026 · since FY2017: -$7.8M → -$1.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$1.3M | -90.7% |
| FY2025 | -$668,255 | -157.8% |
| FY2024 | $1.2M | -52.7% |
| FY2023 | $2.4M | +136.1% |
| FY2022 | -$6.8M | -298.1% |
| FY2021 | $3.4M | +230.2% |
| FY2020 | -$2.6M | +44.4% |
| FY2019 | -$4.7M | +19.2% |
| FY2018 | -$5.8M | +24.7% |
| FY2017 | -$7.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice